Pattern recognition and cellular immune responses to novel Mycobacterium tuberculosis-antigens in individuals from Belarus

BMC Infectious Diseases

Volumn 12, Issue , 2012, Pages

  Ahmed, Raija K ^a   Rohava, Zoyia ^b   Balaji, Kithiganahalli N ^c   Hoffner, Sven E ^a   Gaines, Hans ^a   Magalhaes, Isabelle ^d   Zumla, Alimuddin ^e   Skrahina, Alena ^b   Maeurer, Markus J ^d,f  

^a SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^b Republican Scientific and Practical Center for Pulmonology and Tuberculosis   (Belarus)

^c INDIAN INSTITUTE OF SCIENCE   (India)

^d KAROLINSKA INSTITUTE   (Sweden)

^e ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^f KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Antigen recognition; Biomarkers; M. tuberculosis; T cells; TB

Indexed keywords

BCG VACCINE; CELL LIPID; CELL MEMBRANE PROTEIN; CYCLOPROPANE FATTY ACYL PHOSPHOLIPID SYNTHASE; EARLY SECRETORY ANTIGENIC TARGET 6; GAMMA INTERFERON; GLYCOSYLTRANSFERASE; GUANINE DINUCLEOTIDE; HEMOLYSIN; INTERLEUKIN 2; ISOCITRATE DEHYDROGENASE; LIPID; LOW MOLECULAR WEIGHT PROTEIN ANTIGEN 7; MOLYBDOPTERIN; MYCOBACTERIUM ANTIGEN; MYCOCEROSIC ACID SYNTHASE; RECOMBINANT PROTEIN; SECRETED ANTIGEN 85A; SECRETED ANTIGEN 85B; SECRETED ESAT 6 LIKE PROTEIN ESXH; SYNTHETASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; BACTERIAL ANTIGEN; DIAGNOSTIC AGENT; MYCOBACTERIUM TUBERCULOSIS ANTIGENS;

ADULT; ARTICLE; BACTERIAL VIRULENCE; BELARUS; CELL METABOLISM; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; GENE TARGETING; HUMAN; LIPID METABOLISM; MALE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PATTERN RECOGNITION; T LYMPHOCYTE; TUBERCULOSIS; CELL CULTURE; IMMUNOLOGY; MIDDLE AGED; MONONUCLEAR CELL; SECRETION;

ADULT; ANTIGENS, BACTERIAL; CELLS, CULTURED; FEMALE; HUMANS; IMMUNITY, CELLULAR; INTERFERON-GAMMA; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; REPUBLIC OF BELARUS;

EID: 84857004803     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-12-41     Document Type: Article

References (37)

1. Titov LP, Zakerbostanabad S, Slizen V, Surkova L, Taghikhani M, Bahrmand A. Molecular characterization of rpoB gene mutations in rifampicine-resistant Mycobacterium tuberculosis isolates from tuberculosis patients in Belarus. Biotechnol J 2006, 1(12):1447-1452. 10.1002/biot.200600153, 17124704.
2. Skrahina A, Hurevich H, Zalutskaya A, Sahalchyk E, Astrauko A, van Gemert W, Hoffner S, Rusovich V, Zignol M. Alarming levels of drug-resistant tuberculosis in Belarus: results of a survey in Minsk. Eur Respir J 2011,
3. Grishko AN, Grashchenkova OV, Knoring BE, Gul'el'mi LA, Isaeva N, Petrova LI, Klepatskaia SB, Parmon VM. [Characteristics of prevention of tuberculosis in the conditions of low prevalence of tuberculous infection]. Probl Tuberk 1992, 7-8:6-8.
4. Bubochkin BP, Ivanova ES. Specific prevention of tuberculosis in young patients by BCG vaccine. Probl Tuberk 1991, 3:16-19.
5. Manuel O, Kumar D. QuantiFERON-TB Gold assay for the diagnosis of latent tuberculosis infection. Expert Rev Mol Diagn 2008, 8(3):247-256. 10.1586/14737159.8.3.247, 18598104.
6. Connell TG, Rangaka MX, Curtis N, Wilkinson RJ. QuantiFERON-TB Gold: state of the art for the diagnosis of tuberculosis infection?. Expert Rev Mol Diagn 2006, 6(5):663-677. 10.1586/14737159.6.5.663, 17009902.
7. Mazurek GH, Weis SE, Moonan PK, Daley CL, Bernardo J, Lardizabal AA, Reves RR, Toney SR, Daniels LJ, LoBue PA. Prospective comparison of the tuberculin skin test and 2 whole-blood interferon-gamma release assays in persons with suspected tuberculosis. Clin Infect Dis 2007, 45(7):837-845. 10.1086/521107, 17806047.
8. Flynn JL, Chan J. Tuberculosis: latency and reactivation. Infect Immun 2001, 69(7):4195-4201. 10.1128/IAI.69.7.4195-4201.2001, 98451, 11401954.
9. Munoz-Elias EJ, Timm J, Botha T, Chan WT, Gomez JE, McKinney JD. Replication dynamics of Mycobacterium tuberculosis in chronically infected mice. Infect Immun 2005, 73(1):546-551. 10.1128/IAI.73.1.546-551.2005, 538940, 15618194.
10. Boon C, Dick T. Mycobacterium bovis BCG response regulator essential for hypoxic dormancy. J Bacteriol 2002, 184(24):6760-6767. 10.1128/JB.184.24.6760-6767.2002, 135468, 12446625.
11. Voskuil MI, Schnappinger D, Visconti KC, Harrell MI, Dolganov GM, Sherman DR, Schoolnik GK. Inhibition of respiration by nitric oxide induces a Mycobacterium tuberculosis dormancy program. J Exp Med 2003, 198(5):705-713. 10.1084/jem.20030205, 2194188, 12953092.
12. Sherman DR, Voskuil M, Schnappinger D, Liao R, Harrell MI, Schoolnik GK. Regulation of the Mycobacterium tuberculosis hypoxic response gene encoding alpha -crystallin. Proc Natl Acad Sci USA 2001, 98(13):7534-7539. 10.1073/pnas.121172498, 34703, 11416222.
13. Lin MY, Ottenhoff TH. Not to wake a sleeping giant: new insights into host-pathogen interactions identify new targets for vaccination against latent Mycobacterium tuberculosis infection. Biol Chem 2008, 389(5):497-511. 10.1515/BC.2008.057, 18953716.
14. Demissie A, Leyten EM, Abebe M, Wassie L, Aseffa A, Abate G, Fletcher H, Owiafe P, Hill PC, Brookes R, et al. Recognition of stage-specific mycobacterial antigens differentiates between acute and latent infections with Mycobacterium tuberculosis. Clin Vaccine Immunol 2006, 13(2):179-186. 10.1128/CVI.13.2.179-186.2006, 1391929, 16467323.
15. Voskuil MI. Mycobacterium tuberculosis gene expression during environmental conditions associated with latency. Tuberculosis (Edinb) 2004, 84(3-4):138-143.
16. Gaseitsiwe S, Valentini D, Mahdavifar S, Magalhaes I, Hoft DF, Zerweck J, Schutkowski M, Andersson J, Reilly M, Maeurer MJ. Pattern recognition in pulmonary tuberculosis defined by high content peptide microarray chip analysis representing 61 proteins from M. tuberculosis. PLoS One 2008, 3(12):e3840. 10.1371/journal.pone.0003840, 2588537, 19065269.
17. Gaseitsiwe S, Maeurer MJ. Identification of MHC class II binding peptides: microarray and soluble MHC class II molecules. Methods Mol Biol 2009, 524:417-426. 10.1007/978-1-59745-450-6_30, 19377962.
18. Narayana Y, Joshi B, Katoch VM, Mishra KC, Balaji KN. Differential B-cell responses are induced by Mycobacterium tuberculosis PE antigens Rv1169c, Rv0978c, and Rv1818c. Clin Vaccine Immunol 2007, 14(10):1334-1341. 10.1128/CVI.00181-07, 2168116, 17687113.
19. Bansal K, Elluru SR, Narayana Y, Chaturvedi R, Patil SA, Kaveri SV, Bayry J, Balaji KN. PE_PGRS antigens of Mycobacterium tuberculosis induce maturation and activation of human dendritic cells. J Immunol 2010, 184(7):3495-3504. 10.4049/jimmunol.0903299, 20176745.
20. Bansal K, Sinha AY, Ghorpade DS, Togarsimalemath SK, Patil SA, Kaveri SV, Balaji KN, Bayry J. Src homology 3-interacting domain of Rv1917c of Mycobacterium tuberculosis induces selective maturation of human dendritic cells by regulating PI3K-MAPK-NF-kappaB signaling and drives Th2 immune responses. J Biol Chem 2010, 285(47):36511-36522. 10.1074/jbc.M110.158055, 2978579, 20837474.
21. Chaturvedi R, Bansal K, Narayana Y, Kapoor N, Sukumar N, Togarsimalemath SK, Chandra N, Mishra S, Ajitkumar P, Joshi B, et al. The multifunctional PE_PGRS11 protein from Mycobacterium tuberculosis plays a role in regulating resistance to oxidative stress. J Biol Chem 2010, 285(40):30389-30403. 10.1074/jbc.M110.135251, 2945531, 20558725.
22. Gaines H, Biberfeld G. Measurement of lymphoproliferation at the single-cell level by flow cytometry. Methods Mol Biol 2000, 134:243-255.
23. Ahmed RK, Maeurer MJ. T-cell epitope mapping. Methods Mol Biol 2009, 524:427-438. 10.1007/978-1-59745-450-6_31, 19377963.
24. Magalhaes I, Sizemore DR, Ahmed RK, Mueller S, Wehlin L, Scanga C, Weichold F, Schirru G, Pau MG, Goudsmit J, et al. rBCG induces strong antigen-specific T cell responses in rhesus macaques in a prime-boost setting with an adenovirus 35 tuberculosis vaccine vector. PLoS One 2008, 3(11):e3790. 10.1371/journal.pone.0003790, 2582491, 19023426.
25. Magalhaes I, Vudattu NK, Ahmed RK, Kuhlmann-Berenzon S, Ngo Y, Sizemore DR, Wehlin L, Weichold F, Andersson J, Skeiky YA, et al. High content cellular immune profiling reveals differences between rhesus monkeys and men. Immunology 2010, 131(1):128-140. 2966765, 20465573.
26. Hasan Z, Rao N, Salahuddin N, Islam M, Ashraf M, Rottenberg ME, Hussain R. M. tuberculosis sonicate induced IFNgamma, CXCL10 and IL10 can differentiate severity in tuberculosis. Scand J Immunol 2011, 75:220-226.
27. Miller BH, Shinnick TM. Evaluation of Mycobacterium tuberculosis genes involved in resistance to killing by human macrophages. Infect Immun 2000, 68(1):387-390. 10.1128/IAI.68.1.387-390.2000, 97146, 10603413.
28. Bao X, Katz S, Pollard M, Ohlrogge J. Carbocyclic fatty acids in plants: biochemical and molecular genetics characterization of cyclopropane fatty acid synthesis of Sterculiafoetida. Proc Natl Acad Sci USA 2002, 99(10):7172-7177. 10.1073/pnas.092152999, 124547, 11997456.
29. Grogan DW, Cronan JE. Cyclopropane ring formation in membrane lipids of bacteria. Microbiol Mol Biol Rev 1997, 61(4):429-441. 232619, 9409147.
30. Barkan D, Liu Z, Sacchettini JC, Glickman MS. Mycolic acid cyclopropanation is essential for viability, drug resistance, and cell wall integrity of Mycobacterium tuberculosis. Chem Biol 2009, 16(5):499-509. 10.1016/j.chembiol.2009.04.001, 2731493, 19477414.
31. Huang CC, Smith CV, Glickman MS, Jacobs WR, Sacchettini JC. Crystal structures of mycolic acid cyclopropane synthases from Mycobacterium tuberculosis. J Biol Chem 2002, 277(13):11559-11569. 10.1074/jbc.M111698200, 11756461.
32. Rao V, Fujiwara N, Porcelli SA, Glickman MS. Mycobacterium tuberculosis controls host innate immune activation through cyclopropane modification of a glycolipid effector molecule. J Exp Med 2005, 201(4):535-543. 10.1084/jem.20041668, 2213067, 15710652.
33. Charoenwong D, Andrews S, Mackey B. Role of rpoS in the development of cell envelope resilience and pressure resistance in stationary-phase Escherichia coli. Appl Environ Microbiol 2011, 77(15):5220-5229. 10.1128/AEM.00648-11, 3147466, 21705547.
34. van Zyl-Smit RN, Pai M, Peprah K, Meldau R, Kieck J, Juritz J, Badri M, Zumla A, Sechi LA, Bateman ED, et al. Within-subject variability and boosting of T-cell interferon-gamma responses after tuberculin skin testing. Am J Respir Crit Care Med 2009, 180(1):49-58. 10.1164/rccm.200811-1704OC, 19342414.
35. Al-Attiyah R, Madi N, El-Shamy AS, Wiker H, Andersen P, Mustafa A. Cytokine profiles in tuberculosis patients and healthy subjects in response to complex and single antigens of Mycobacterium tuberculosis. FEMS Immunol Med Microbiol 2006, 47(2):254-261. 10.1111/j.1574-695X.2006.00110.x, 16831212.
36. Sherman DR, Gagneux S. Estimating the mutation rate of Mycobacterium tuberculosis during infection. Nat Genet 2011, 43(5):400-401. 10.1038/ng.815, 21522177.
37. Krishnan N, Malaga W, Constant P, Caws M, Tran TH, Salmons J, Nguyen TN, Nguyen DB, Daffe M, Young DB, et al. Mycobacterium tuberculosis lineage influences innate immune response and virulence and is associated with distinct cell envelope lipid profiles. PLoS One 2011, 6(9):e23870. 10.1371/journal.pone.0023870, 3169546, 21931620.